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ABSTRACT
The aim of the present study was to prepare surfactant-free
pseudolatexes of various methacrylic acid copolymers. These
aqueous colloidal dispersions of polymeric materials for oral
administration are intended for film coating of solid dosage
forms or for direct manufacturing of nanoparticles. Nano-
particulate dispersions were produced by an emulsification-
diffusion method involving the use of partially water-miscible
solvents and the mutual saturation of the aqueous and organic
phases prior to the emulsification in order to reduce the initial
thermodynamic instability of the emulsion. Because of the
self-emulsifying properties of the methacrylic acid copoly-
mers, it was possible to prepare aqueous dispersions of col-
loidal size containing up to 30% wt/vol of Eudragit RL, RS,
and E using 2-butanone or methyl acetate as partially water-
miscible solvents, but without any surfactant. However, in the
case of the cationic Eudragit E, protonation of the tertiary
amine groups by acidification of the aqueous phase was nec-
essary to improve the emulsion stability in the absence of
surfactant and subsequently to prevent droplet coalescence
during evaporation. In addition, a pseudolatex of Eudragit E
was used to validate the coating properties of the formulation
for solid dosage forms. Film-coated tablets of quinidine sul-
fate showed a transparent glossy continuous film that was
firmly attached to the tablet. The dissolution profile of quini-
dine sulfate from the tablets coated with the Eudragit E pseu-
dolatex was comparable to that of tablets coated with an
acetonic solution of Eudragit E. Furthermore, both types of
coating ensured similar taste masking. The emulsification-
evaporation method used was shown to be appropriate for
the preparation of surfactant-free colloidal dispersions of
the 3 types of preformed methacrylic acid copolymers; the
dispersions can subsequently be used for film coating of
solid dosage forms.
KEYWORDS: Pseudolatex, methacrylic acid copolymers,
Eudragit, emulsification-diffusion method, nanoparticles,
film coating, quinidine sulfateR
INTRODUCTION
The first methods used to produce nanoparticles were de-
veloped by polymer chemists in the field of latex engineer-
ing and were later adapted for pharmaceutical applications.
Nanoparticles are prepared by several techniques involving
either in situ polymerization of monomers (latex) or disper-
sion of preformed polymers (pseudolatex or artificial latex).
Methods using well-characterized polymers may be pre-
ferred, given the presence of toxic residues (namely un-
reacted monomer, initiator, and emulsifier molecules) in the
polymerization reactions.1,2 The emulsification-evaporation
method for pharmaceutical use was proposed first by
Gurny et al3 and is based on a patent by Vanderhoff et al4
where a polymer is dissolved in a volatile water-immiscible
organic solvent. The organic solution is dispersed in an
aqueous phase containing an emulsifier and easily forms an
oil-in-water (o/w) emulsion. However, the addition of sta-
bilizers is often required to avoid the formation of polymer
flakes. Continuous emulsification under stirring prevents coa-
lescence of the organic droplets and can be further improved
by sonication or microfluidization.1,5-8 The emulsification-
evaporation method is interesting for many reasons: the
use of pharmaceutically acceptable organic solvents, high
yields, good reproducibility, and easy scaling up. A fur-
ther step has been achieved with the development of the
emulsification-diffusion method described by Leroux et al9
and Quintanar-Guerrero et al.10,11 This process involves
(1) the mutual saturation of the organic and the aqueous
phases prior to the emulsification, (2) the dispersion of a
partially water-miscible solvent with the dissolved polymer
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into an aqueous phase containing a stabilizer, and (3) the
addition of a large amount of pure water that provokes the
diffusion of the solvent and the aggregation of the polymer
as nanoparticles.10 With this method, it is necessary to
remove a considerable amount of water to obtain a high
polymer concentration.5
It is, however, worth noting that both methods use a surfac-
tant in order to emulsify and prevent the aggregation during
the diffusion process. In this respect, it is of utmost interest
to develop preparation procedures that avoid surfactants.
The aim of the present study was to use the emulsification-
diffusion technique to produce surfactant-free nanoparticles
of methacrylic acid copolymers (Eudragit RL, RS, and E)
in a high concentration for film coating. The influence of
some process parameters on the nanoparticle size, such as
the type of polymer and its concentration in the organic
phase, the stirring rate, the pH, and the type and concen-
tration of stabilizing agents, has been investigated. A pseu-
dolatex of Eudragit E prepared with the proposed method
was used for the coating of solid dosage forms to assess the
film-forming properties and to verify the surface morphol-
ogy of tablets by scanning electron microscopy.
MATERIALS AND METHODS
Materials
Quinidine sulfate was purchased from Hanseler (Herisau,
Switzerland). Eudragit E, RL, and RS with an average mo-
lecular weight of 150 kDa were a gift from Degussa (Darm-
stadt, Germany). Eudragit E is a cationic copolymer based
on dimethylaminoethyl methacrylate and neutral meth-
acrylic esters. Eudragit RS and RL are copolymers of acrylic
and methacrylic acid esters containing between 4.5% and
6.8%, and 8.8% and 12%, of quaternary ammonium groups,
respectively. The chemical structures of methacrylate co-
polymers used are shown in Figure 1. In the case of Eu-
dragit E pseudolatex, 2 nonionic stabilizing agents were
tested: poloxamers 188 and 407 (BASF, Ludwigshafen, Ger-
many). Two partially water-miscible solvents of analytical
grade, namely 2-butanone (water solubility = 275 mg/mL,
boiling point 80-C, ρ = 0.80 g/mL) and methyl acetate
(water solubility = 280 mg/mL, bp 57-C, ρ = 0.93 g/mL,
experimental determinations), were used as solvents for
the Eudragit grades and purchased from Fluka (Buchs,
Switzerland). Acetic acid of analytical grade was added to
adjust the pH in the aqueous phase in the emulsion, and
tributyl citrate was used as a plasticizer for the coating of
tablets. Other chemicals were of analytical grade and used
as received.
Methods
Pseudolatex Preparation
Nanoparticles were produced according to the emulsification-
diffusion method described previously,5,12 where 2-butanone
(or methyl acetate) and water were mutually saturated be-
fore use to ensure the initial thermodynamic equilibrium of
both liquids. Typically, 4 g of Eudragit were dissolved in
20 mL of the water-saturated 2-butanone. This organic so-
lution was emulsified with 40 mL of 2-butanone-saturated
aqueous solution under mechanical stirring at 2000 rpm
for 15 minutes. Batches of Eudragit E emulsions were pre-
pared using either decreasing amounts of poloxamer as a
stabilizer or acetic acid to reduce the pH of the aqueous
phase prior to the emulsification to improve the stability of
the emulsion. Extraction of the solvent from the nanodrop-
lets was achieved by evaporation at 40-C in a rotary evap-
orator under reduced pressure (200 mmHg) for 15 minutes,
leading to the formation of nanoparticles by precipitation
of the macromolecules. The recovered solvent was reused
to prepare new batches, except for those with acetic acid.
The mean particle size and polydispersity index (PI) of the
nanoparticles were determined 3 times by photon correla-
tion spectroscopy using a Zetasizer 5000 (Malvern, Worces-
tershire, UK). Using the same instrument mounted with
an electrophoretic cell, the zeta potential (ζ) of Eudragit
nanoparticles was determined from the electrophoretic mo-
bility measurements at 25-C. Scanning electron micros-
copy (SEM) (JEOL, Tokyo, Japan) was used to examine
the surface of the nanoparticles. Samples were prepared on
metallic studs and coated with a gold film (20 nm).
Interfacial Tension Determination
The interfacial tension at the solvent-water interface was
determined by the Du Noüy method using a digital-
tensiometer K10 (Krüss, Hamburg, Germany) with a plati-
num ring. The temperature was kept constant at 20-C by
circulating thermostated water through a jacketed vesselFigure 1. Chemical structure of the Eudragit types used.
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containing the sample. Each determination was repeated
in triplicate, and the average results were reported. The
experimental uncertainty of interfacial tension determina-
tion was ~0.1 mN/m.
Preparation and Characterization of Coated Tablets
Convex tablets of 10 mm in diameter (curvature radius
8.5 mm) containing 15 mg of quinidine sulfate were pre-
pared. The concentration of Eudragit E in the pseudolatex
(80 mL) was adjusted to 10% (wt/vol). This suspension was
used as a coating dispersion in a Hi-Coater HCT-20 Mini
(Gebrüder Lödige, Paderborn, Germany) equipped with a
Gilson Minipuls 3 pump (Villiers-le-Bel, France). Tributyl
citrate (0.8 g) was added as a plasticizer to the pseudolatex
10 minutes prior to the coating under magnetic stirring.
Details of the operating conditions appear in Table 1. A
second batch of tablets was coated using the same pro-
cedure with a 10% (wt/vol) acetonic solution of Eudragit E
added with 1% (wt/vol) tributyl citrate. The operating con-
ditions were identical to the suspension, except for the dry-
ing air temperature, which was lowered to 40-C.
Coated tablets were examined for their mean disintegration
time and their dissolution rate. The disintegration time was
determined according to the European Pharmacopeia with
HCl 0.1M. The dissolution test was performed with 6 in-
dividual tablets in 900 mL of HCl 0.1M at 37-C using
the European Pharmacopoeia paddle apparatus at 50 rpm.
The amount of quinidine sulfate dissolved was measured
spectrophotometrically at 251 nm using an automated sam-
pling system (Hewlett Packard 8453). Coated tablets were
evaluated with regard to duration of taste-masking time by
a group of 6 volunteers selected according to the European
Pharmacopeia for their sensitivity to bitterness using qui-
nine hydrochloride solutions. Tablets were kept immobile
in the oral cavity until dissolution of the coating and sub-
sequent bitterness perception. Tests were performed in trip-
licate. The surface morphology and the film thickness of the
coated tablets were examined by SEM.
RESULTS AND DISCUSSION
The proposed emulsification-diffusion method without emul-
sifier enabled the preparation of nanoparticles of Eudragit
RL, RS, and E at high concentrations of 20% (wt/vol) with
2-butanone or methyl acetate as partially water-miscible
solvents (Table 2). The particle size data suggest that it is
possible to form pseudolatexes from a conventional o/w
emulsion without emulsifier by a simple extraction of the
solvent from the nanodroplets. The displacement of the
solvent in a rotary evaporator under reduced pressure led to
the in situ precipitation of the polymer and the formation of
stable nanoparticles. In the case of Eudragit E, particles of
colloidal size free of stabilizer were obtained only by
lowering the pH to obviate some solubility of the polymer
in the aqueous phase.
The preparation of a stable emulsion is crucial in order to
avoid the coalescence of nanodroplets that occurs during
the emulsification and evaporation step. In particular, spe-
cific requirements must be satisfied, such as a small differ-
ence in density between the dispersed and the continuous
phase, a high viscosity of the continuous phase, a low in-
terfacial tension, the existence of an electrical double layer
at the oil/water interface according to the Derjaguin-Landau-
Verwey-Overbeek (DLVO) theory, and the mechanical
strength of the adsorbed layer at the oil/water interface.13
In these experiments, the density and the viscosity could not
account for the emulsion stability. Therefore, a low inter-
facial tension, the electrical double layer, and the mechanical
strength of the adsorbed layer may be the most important
parameters to increase the stability of the emulsion.
Role of the Interfacial Tension
From the photon correlation spectroscopy measurements,
the size of nanoparticles of Eudragit RL prepared using
2-butanone and methyl acetate were, respectively, 66 and
75 nm, with a PI smaller than 0.14, indicating a narrow
unimodal pattern (Table 2). With Eudragit RS, the aver-
age sizes were 121 nm (2-butanone) and 127 nm (methyl
acetate), with a PI around 0.17. These data are supported
by the interfacial tension values, which were always less
than 1 mN/m (1.8 mN/m for the water–methyl acetate sys-
tem), indicating that using partially miscible water solvents
actually decreases the interfacial tension. For comparison,
the interfacial tension between a poorly soluble solvent
such as chloroform (7 mg/mL) and water was 33 mN/m. As
a result, the preparation of Eudragit RL pseudolatex using
chloroform as a solvent was not possible and led to a mas-
sive aggregation of particles (Table 2). Saito et al13 and
Table 1. Operating Conditions for the HCT-20 Mini
Tablet Charge 350 g of 10-mm Convex
Tablets Containing 15 mg
of Quinidine Sulfate Each
Eudragit E pseudolatex
20% (wt/vol)
80 mL
Pan rotation 10 rpm
Preheating time 5 minutes
Drying air temperature 55-60-C
Feed, and spraying air pressure 2 mL/min at 0.8 kg/cm2
Exhaust air 33-35-C
Final drying time 5 minutes
Coating time 50 minutes
Coating weight 2.5% of tablet weight
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recently Chernysheva et al14 have confirmed that lowering
the interfacial tension is effective for increasing the o/w
emulsion stability.
In the same experimental conditions, when water and methyl
acetate were not mutually saturated prior to the emulsifica-
tion, 2 populations of nanoparticles (with modes of 360 and
120 nm, total average size = 134 nm, PI = 0.248) were
observed in the pseudolatex of Eudragit RS (see batch 5 in
Table 2). This indicated that saturating the dispersed and
the external phases can decrease the initial thermodynamic
instability when both phases are mixed together.
Role of the Electrical Double Layer
The presence of Eudragit RS or RL in the solvent reduced
the interfacial tension values below the limit of determi-
nation (1 mN/m) of the tensiometer. The low interfacial ten-
sion may be explained by the formation of electrical double
layers of ions and charged adsorption layers by Eudragit
quaternary ammonium groups. The hydrophilic and lipo-
philic moieties of Eudragit RS or RL caused the polymer
chains to orient themselves at the interface between the or-
ganic phase and the aqueous phase.
From the o/w emulsion standpoint, polycationic copoly-
mers such as Eudragit RS and RL may provide even more
stability. Because of the quaternary ammonium groups of
the macromolecules, the oil droplets are covered with a
positively charged surface, repelling each other and further
stabilizing the emulsion. Zeta potential (ζ ) determinations
confirmed that Eudragit RL and RS nanoparticles were
positively charged, with values of 64.5 ± 2.4 mVand 57.1 ±
2.2 mV, respectively. The difference in size of nanoparticles
of Eudragit RL (66 and 75 nm) and Eudragit RS (121 and
127 nm) may be explained by the higher density of qua-
ternary ammonium groups in Eudragit RL. These results are
in accordance with Lehmann et al,15 who have established
excellent self-emulsifying properties of Eudragit RL and
RS, recently confirmed by the work of Chernysheva et al.14
Role of the Adsorbed Layer
Tertiary amine groups in Eudragit E preferably are ori-
ented at the liquid-liquid interface. This can provide the
polymer with some hydrophilic character (Figure 1). Fur-
thermore, it was possible to obtain homogeneous emulsions
of Eudragit E, but the droplets coalesced during the evap-
oration step, because of insufficient stabilization. The pseu-
dolatexes obtained showed dispersed microparticles of around
2.2 µm (PI = 0.381). Polymer flakes were also visible on the
surface of these batches (Table 2). Increasing the stirring
rate from 2000 rpm to 5000 rpm decreased neither the size
of particles nor the PI. The ζ value of these microparticles
was as low as 18.5 ± 2.3 mV, indicating that the electrical
repulsion played a minor role in the stabilization of the
emulsion. It was concluded that the mechanism involved
was mainly the steric repulsion, which acts by an excess of
polymer chains and the elastic deformation. First, polymer
Table 2. Eudragit Pseudolatexes Produced*
Batch
No Eudragit Type Solvent
Acetic Acid (mL)
(pH Measured)
Stabilizer
(% wt/vol)
Mean Size
(nm) ± SD†
Polydispersity
Index Aggregation‡
1 RL 2-Butanone — 0 66 ± 9 0.133 –
2 RL MeOAc — 0 75 ± 11 0.139 –
3 RS 2-Butanone — 0 121 ± 10 0.161 –
4 RS MeOAc — 0 127 ± 12 0.176 –
5§ RS MeOAc — 0 134 ± 15 0.248 –
6 E 2-Butanone — 0 2240 ± 112 0.381 +
7║ E 2-Butanone — 0 2160 ± 141 0.355 +
8 E 2-Butanone — F-68 (1.0) 399 ± 35 0.202 +
9 E 2-Butanone — F-127 (1.0) 304 ± 17 0.149 –
10 E 2-Butanone — F-127 (0.5) 366 ± 22 0.196 +
11 E 2-Butanone 0.5 (pH = 6.3) 0 279 ± 17 0.208 +
12 E 2-Butanone 1 (pH = 5.0) 0 245 ± 8 0.142 –
13 E (10%) 2-Butanone 1 (pH = 5.0) 0 241 ± 7 0.139 –
14 E (30%) 2-Butanone 1.08 (pH = 5.0) 0 353 ± 15 0.251 –
15 E (40%) 2-Butanone 1.15 (pH = 5.0) 0 1350 ± 55 0.307 –
16 E MeOAc 1 (pH = 5.0) 0 256 ± 6 0.167 –
17 RL Chloroform — 0 — — +++
*Organic phase: 20 mL (polymer 20% wt/vol); aqueous phase: 40 mL; stirring rate: 2000 rpm. MeOAc indicates methyl acetate.
†n = 3.
‡Polymer aggregation on the surface after evaporation: (–) not observed, (+) observed, and (+++) massive.
§No mutual saturation of internal and external phases prior to emulsification.
║Stirring rate: 5000 rpm.
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chains dissolved in droplets may present their hydrophilic
moieties at the interface of both phases; when 2 particles
approach each other the polymer layers start to overlap. This
leads to a local decrease in water concentration and sets up
an osmotic pressure gradient. Water flows in to dilute the
concentrated polymer, and the particles move apart. Second,
the polymer layer can also act as an integral mechanical
strength, which tends to repel an approaching particle by
the elastic deformation of the droplets. The stabilization of
the emulsion by the steric repulsion may be reduced dur-
ing the evaporation step. As the volume of solvent decreases
in the droplets, the polymer concentration increases, fol-
lowed by an increase in viscosity. Consequently, the elas-
tic deformation of droplets is reduced, leading to polymer
aggregation.
It was necessary to use poloxamer 407 at a minimum con-
centration of 1% (wt/vol) in the aqueous phase to obtain
homogeneously dispersed colloidal particles of Eudragit E.
Nanoparticles obtained with this emulsifier were around
300 nm (PI = 0.149). Decreasing the concentration of po-
loxamer 407 to 0.5% (wt/vol) or using poloxamer 188 even
at 1.0% (wt/vol) was less effective in stabilizing the emul-
sion. The benefits of poloxamer as an emulsifier are the
reduction of the interfacial tension at the droplet surface
and the mechanical and steric stabilization by short-range
repulsion between droplets. In addition, the nonadsorbed
chains of poloxamer can increase the continuous phase vis-
cosity, allowing the disruption kinetics to smaller droplets
and promoting the hydrodynamic stabilization.16,17 These
actions prevent the collision and coalescence of nano-
droplets during the emulsification and evaporation steps.
Protonation of Eudragit E
Hydrophilic regions allowed the Eudragit E chains to be
oriented at the water-solvent interface of droplets. Despite
the adsorption of polymer chains and the consecutive decrease
in the interfacial tension, the steric repulsion mechanism
was reduced during the evaporation step, leading to particles
of over 1 μm and polymer flakes. From pseudolatexes of
Eudragit RL or RS, it was concluded that polymers with
charged groups such as quaternary ammonium moieties
were able to cover droplets with a positively charged sur-
face, increasing the stability of the emulsion via electrical
repulsion.
It was possible to produce nanoparticles of Eudragit E
without surfactant by lowering the pH of the aqueous phase
to 5.0 with acetic acid. The sizes were 245 nm (2-butanone,
PI = 0.142) and 256 nm (methyl acetate, PI = 0.167). As
the pH was adjusted to 6.3, nanoparticles around 280 nm
with an increased PI were obtained. Polymer flakes were
also observed with this batch (Table 2). It was concluded
that lowering the pH in the aqueous phase could protonate
the tertiary amine groups of Eudragit E on the surface of
droplets. This could further stabilize the emulsion with the
increase of the electrical repulsion mechanism. At a pH of
6.3, some tertiary amine groups were protonated, but the
corresponding density of charged groups on the surface of
droplets was insufficient for a good stabilization of the
emulsion. In addition, the use of acetic acid was advanta-
geous, because it could be removed during the evaporation
of the solvent in the rotary evaporator.
Under the same optimal conditions (pH = 5.0), the in-
fluence of Eudragit E concentration in the dispersed phase
on particle size was also evaluated. At a concentration of
10% (polymer to 2-butanone), the nanoparticles obtained
were similar in size and PI to those previously prepared
(20% wt/vol). With a concentration of 30% (wt/vol) of poly-
mer, the nanoparticles obtained were significantly larger,
with an increased PI (Table 2). At 40% wt/vol, particle size
was drastically increased to the micrometer range, and
2 populations of particles were observed using photon cor-
relation spectroscopy.
Figure 2. Surface of an uncoated tablet (A) and of a final tablet coated with a Eudragit E pseudolatex (B).
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Evaluation of the Coated Tablets
A sufficient amount of pseudolatex of Eudragit E (80 mL)
was prepared under the same experimental conditions as
for batch 12 (Table 2). This suspension was used in a Hi-
Coater HCT-20 Mini to verify its coating properties. The
concentration of the polymer was adjusted to 10% (wt/vol)
in the pseudolatex, and 0.8 g of tributyl citrate was added
as a plasticizer. Details of the operating conditions appear
in Table 1.
The coated tablets had a transparent glossy continuous film,
as confirmed by SEM (Figure 2B). The surface of the film,
which was firmly attached to the tablet, was regular, and
pores were not visible, unlike the surface of uncoated tab-
lets (Figure 2A). The thickness of the film during the coating
process was evaluated from micrographs of the cross-
sectional area of tablets and was found to be 27.1 ± 2.9 µm
on the final tablets. That film corresponded to a coating
weight of 2.8 mg/cm2. The mean disintegration time of
tablets was 2.3 ± 0.6 minutes, while that for uncoated tab-
lets was 1.4 ± 0.7 minutes. At an equivalent coating weight,
the dissolution profile of quinidine sulfate from tablets
coated with the pseudolatex of Eudragit E was comparable
to that of the organic solution of Eudragit E (Figure 3).
As expected for an aqueous suspension, the coating made
of pseudolatex showed a slightly faster release in the early
period than it did later. This demonstrates the value of
pseudolatex of Eudragit E as a coating formulation. Fi-
nally, coated tablets were evaluated with regard to dura-
tion of taste-masking time. In both cases, no bitterness
perception of quinidine sulfate was detected over a period
of 15 minutes. The average time of taste masking was
22.8 ± 5.4 minutes for the pseudolatex coating and 24.5 ±
4.2 minutes for the organic coating, respectively.
CONCLUSION
Through the use of a solvent partially miscible with water
in the emulsification-diffusion method, it has been possible
to prepare pseudolatexes of Eudragit RL, RS, and E with-
out any additive. The stabilizing parameters of the emul-
sion are the low interfacial tension, the electrical double
layer, and the mechanical strength of the adsorbed layer. In
addition, the preliminary mutual saturation of the aqueous
and organic phases is necessary to reduce the initial ther-
modynamic instability of the emulsion.
As expected for pseudolatexes, the particle size of the
colloidal dispersions produced here was higher than that of
the so-called true latexes obtained by emulsion polymer-
ization of acrylic monomers, but there was no detrimental
effect on the film-forming properties, as shown for a Eu-
dragit E pseudolatex with quinidine sulfate tablets. In con-
trast, the main advantage of preparing colloidal dispersions
from preformed methacrylic acid copolymers is the absence
of surfactant, which is generally present in true latexes.
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